Affiliations 

  • 1 1 AIDS Program, Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut
  • 2 3 Asociación Civil Impacta Salud y Educación, Lima, Peru
  • 3 4 Yale College, New Haven, Connecticut
  • 4 5 Asociación Vía Libre, Lima, Peru
  • 5 6 Infectious Diseases Unit, Hospital Nacional Arzobispo Loayza, Lima, Peru
  • 6 7 Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut
  • 7 8 Infectious Diseases Unit, Hospital Nacional Dos de Mayo, Lima, Peru
LGBT Health, 2018;5(8):477-483.
PMID: 30874476 DOI: 10.1089/lgbt.2017.0186

Abstract

PURPOSE: Globally, transgender women (TGW) experience a high burden of adverse health outcomes, including a high prevalence of HIV and sexually transmitted infections (STIs) as well as psychiatric disorders and substance use disorders. To address gaps in HIV research in Peru focused specifically on TGW, this study presents characteristics of a sample of HIV-positive TGW and identifies factors associated with viral suppression.

METHODS: Between June 2015 and August 2016, 50 HIV-positive TGW were recruited in Lima, Peru. Multivariable logistic regression was used to identify factors associated with viral suppression (<200 copies/mL) among the TGW.

RESULTS: Among TGW, 85% achieved viral suppression. Approximately half (54%) reported anal sex with more than five partners in the past 6 months, 38% reported sex work, 68% had not disclosed their HIV status to one or more of their partners, and 38% reported condomless sex with their last partner. The prevalence of alcohol use disorders was high (54%), and 38% reported use of drugs in the past year. Moderate-to-severe drug use significantly reduced odds of achieving viral suppression (adjusted odds ratio 0.69; 95% confidence interval: 0.48-0.98).

CONCLUSION: Our findings highlight the need for integrated treatment for substance disorders in HIV care to increase the viral suppression rate among TGW in Lima, Peru.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.